Recep Adiyaman
Vision About Experience Education Skills Publications Tools Newsletter Updates Podcasts Blog Contact CV Subscribe
All Issues
Older Newer
Daily Signal January 26, 2026 · 8 min read

Issue #32: Energy-Driven Innovations in Computational De Novo Protein Engineering.

Protein Design Digest - 2026-01-26 - Energy-Driven Innovations in Computational De Novo Protein Engineering.

Share X LinkedIn
Protein Design Daily

Building something in Protein Design?

I love collaborating on new challenges. Let's build together.

LinkedIn Email

Subscribe to Protein Design Digest

Daily curated signals from arXiv, PubMed, and BioRxiv.

Signal of the Day

Energy-Driven Innovations in Computational De Novo Protein Engineering.

Energy models play a crucial role in the advancement of computational de novo protein engineering, enabling the design of novel proteins with tailored functionalities. Proteins serve as the foundation of biochemical processes, making their precise engineering essential for applications in biotechnology, medicine, and synthetic biology. Unlike traditional approaches that focus on modifying existing proteins, de novo engineering introduces entirely new constructs, a paradigm shift driven by energy-based strategies that guide protein folding, stability, and functionality through comprehensive simulations of energy landscapes. Computational techniques such as molecular dynamics (MD), thermodynamic integration, and Monte Carlo sampling are fundamental in evaluating designed proteins’ stability and dynamic behavior. Widely used tools such as CHARMM, Amber, and Rosetta leverage advanced energy functions to optimize protein structures, facilitating accurate predictions of folding pathways and binding affinities. Additionally, the integration of machine learning (ML) and deep learning (DL) has significantly improved the speed and precision of energy-based modeling, enhancing the design and optimization process. This review systematically analyzes recent studies, provides quantitative benchmarking of major computational platforms, and presents a decision framework for method selection based on accuracy-cost-throughput trade-offs. By integrating classical force fields, quantum mechanical approaches, and AI-driven predictions with experimental validation, this work outlines a roadmap for advancing therapeutic and industrial protein design through synergistic physics-based and data-driven strategies.

Why this matters: Critical for improving fold accuracy and reducing structural uncertainty in de novo design.

Also Worth Reading

Tailored pyrrole-based imidazothiazole scaffolds: Synthetic elaboration, enzyme kinetic profiling and DFT-guided molecular docking toward Antidiabetic therapeutics.

The current research study highlights the successful biological evaluation of novel imidazo-thiadiazole based pyrrole derivatives, with the aim of targeting diabetes mellitus through alpha-amylase and alpha-glucosidase inhibition. These compounds exhibited promising anti-diabetic activity, notably compound 8 emerged as a leading candidate (3.50 ± 0.20, and 4.10 ± 0.10 µM) which outperformed the potential of acarbose (6.20 ± 0.10 and 6.70 ± 0.20 µM), a reference drug. The enhanced biological potential of compound 8 is likely due to incorporation of hydroxyl substituents, which may strengthen its binding affinity and selectivity towards the targeted enzymes. Molecular docking revealed stable interactions with key amino acids residues of targeted enzymes, providing mechanistic basis for its potent inhibitory activity. To further established their therapeutic relevance, enzyme kinetic study was conducted which confirmed their mode of inhibition while ADMET analysis indicated favorable pharmacokinetics and safety profiles. Moreover, pharmacophore modeling and molecular dynamics simulations reinforced the stability and binding efficiency of lead compounds under dynamic biological conditions. All the experimental results and in silico validations demonstrate that potent compounds possess significant anti-diabetic activity profile. Their ability to outperform an existing diabetes mellitus inhibitor and maintaining a favorable safety profile suggest that these compounds have potential to be further used in drug development and optimization against Diabetes Mellitus.

Identification of novel umami peptides in fermented milk and elucidation of their umami mechanism via molecular docking and molecular dynamics simulations.

A streamlined workflow integrating multi-model machine learning, bioinformatics filtering, sensory evaluation, molecular docking and dynamics simulations was applied to mine umami peptides in fermented milk. Based on dual selection criteria-(i) unanimous umami prediction by UMPred-FRL, Umami_YYDS, Umami-MRNN, Mlp4Umami, Umami_TD, (ii) favorable in silico properties (non-toxicity, non-allergenicity, good solubility, stability, potential bioactivity)-ten out of the 1505 peptides identified by peptidomics were shortlisted as umami peptide candidates. Sensory evaluation confirmed that eight imparted an umami taste. Molecular docking revealed that umami peptides interact with TAS1R1/TAS1R3 primarily through hydrogen bonds formed between their hydrophilic residues (predominantly Lys, Tyr) and receptor hydrophilic residues (notably Lys/Arg in TAS1R1, Asn in TAS1R3). Residues Arg307/Met375/Lys379 of TAS1R1, and Arg327/443/Ala329/Val437/Met452 of TAS1R3 were key interaction sites. Molecular dynamics simulations showed that the three peptides with the highest umami taste-EVFTKK, SKKTVDME, VMGVSKVKE-formed stable and compact complexes with TAS1R1/TAS1R3. This work enhances understanding of the umami characteristics of fermented milk.

2-Aminothiophene and 2-aminothiazole scaffolds as potent antimicrobial agents: Design, synthesis, biological evaluation, and computational insights.

The development of new antitubercular drugs is critically hindered by the persistent and adaptive nature of Mycobacterium tuberculosis (Mtb), underscoring an urgent need for innovative therapeutic strategies. In this work, a series of structurally varied 2-aminothiophene and 2-aminothiazole derivatives was designed, synthesized, and characterized using FT-IR, NMR, HRMS, and single-crystal X-ray techniques. The thiophene analogues were prepared via the Gewald reaction, while thiazole derivatives were obtained through Hantzsch synthesis, with structural diversity achieved by modifying alkyl, ester, and fused ring groups. Several compounds exhibited potent antitubercular activity against Mtb H37Rv, with 4h, 4k, and 4l showing MIC values of 0.78 μg/mL, comparable to the standard drug Ethambutol. SAR studies revealed that linear alkyl chains enhanced activity, whereas aryl and fused rings were less favourable. Additionally, compounds 4q, 4s, 7g, 7o, and 9e emerged as moderate antibacterial leads against both Gram-positive and Gram-negative bacteria. Cytotoxicity assays for the potent compounds were performed in Vero cells and THP-1 cells, supporting a favourable safety profile and selective activity against Mtb. Furthermore, target prediction, molecular docking, along with DFT and ADMET analyses, provided valuable insights into their putative molecular targets, binding modes, and the drug-like and electronic properties that influence bioactivity. Collectively, these results identify compound 4k as a promising lead candidate against Mtb, underscoring the potential of the 2-aminothiophene scaffold as a valuable framework for antitubercular drug discovery. These findings encourage further exploration of 2-aminothiophene and 2-aminothiazole scaffolds by medicinal chemists for the development of novel, potent, and selective antitubercular and antibacterial drug candidates.

Research & AI Updates

From the Industry

Quick Reads

Novel imidazolium salts bearing 2-oxindoles scaffold as potent acetylcholinesterase inhibitors for Alzheimer’s disease: Design, synthesis, in vitro and in silico studies.

In this study, a series of thirty-five novel imidazolium salts bearing a 2-oxindoles were designed and synthesized as potent acetylcholinesterase (AChE) inhibitors for Alzheimer’s disease. Read more →

Identification of phosphodiesterase 10 A modulators for neurodegenerative and psychiatric disorders: Combination of physics-based virtual screening and machine learning approaches.

Phosphodiesterase (PDE) is a crucial enzyme that regulates intracellular signal transduction by breaking down cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) into inactive forms. Read more →

Ternary Complex Geometry and Lysine Positioning Guide the Generation of PROTAC-Induced Degradable Complexes.

Targeted protein degradation via PROTACs (PROteolysis TArgeting Chimaeras) has transformed drug discovery by enabling the elimination of disease-driving proteins, including those previously considered undruggable. Read more →

De novo protein ligand design including protein flexibility and conformational adaptation.

Motivation The rational design of chemical compounds that bind to a desired protein target molecule is a major goal of drug discovery. Read more →

Primary Osteoarthritis of the Sternoclavicular Joint: Surgical Management Using the Sternal Docking Technique.

Dislocation of the sternoclavicular joint (SCJ) is the most common SCJ condition reported to be managed surgically. Read more →

Computational studies of target-specific radiopharmaceuticals for theranostics.

Radiopharmaceuticals are key tools in nuclear medicine, enabling both diagnostic imaging and targeted therapy for conditions such as cancer and neurological disorders. Read more →

Effect of acyl donors on EGCG esterification reaction catalyzed by Lipase “Amano” 30SD based on molecular dynamics analysis.

Enzymatic esterification of (-)-epigallocatechin gallate (EGCG) can improve its lipophilicity and promote its utilization, but acyl donors significantly affect the catalytic efficiency and selectivity of lipase in EGCG esterification. Read more →

Rational design of peptide-based programmed cell death 1 immune checkpoint inhibitors using advanced integrated computational approach.

The programmed cell death protein 1 (PD-1) and its ligand, programmed cell death ligand 1 (PD-L1), constitute a critical immune checkpoint axis frequently exploited by cancer cells to evade immune detection. Read more →

Pipeline Tip

Always validate pLDDT scores before using AlphaFold models for docking.

Resources & Tools

The protein structure is the language of life; design is its poetry. — Recep Adiyaman

BS HF DK